Clinical Trial Detail

NCT ID NCT01853618
Title Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

hepatocellular carcinoma

biliary tract cancer

Therapies

Tremelimumab

Age Groups: adult

No variant requirements are available.